Abstract:Genome-wide association studies (GWASs) have identified dozens of susceptibility loci for sporadic Alzheimer's disease (AD) primarily in Caucasians, but whether the same or different variants account for genetic risks in Chinese remains unknown. A two-stage case-control GWAS was conducted for subjects from 39 hospitals across China. In the discovery stage, 993 AD cases and 6,451 controls passed quality control after genotyping using Illumina HumanOmniZhongHua-8 BeadChips. In the replication stage, 55 top single nucleotide polymorphisms (SNPs) with evidence of associations and eight SNPs previously reported in Caucasians were selected for genotyping using ABI PRISM® SNaPshot™ Multiplex System in an independent cohort of 1,201 AD cases and 4,889 controls. In the combined analysis, seven SNPs had associations exceeding the genome-wide significance threshold (P < 5.0 × 10−8) with no heterogeneity between stages. The overall variance was calculated using the restricted maximum-likelihood method. HaploReg, cis-expression quantitative trait loci (cis-eQTL) database, the Gene Expression Omnibus (GEO) profiles, STRING, and the Gene Ontology enrichment analysis was used to further characterize these seven variants. For the APOE region, multifactor regression analysis using imputed data was performed. Four novel variants were identified with genome-wide significance (P < 5 × 10-8): rs463717 (5q31.3, Pcombined = 8.56 × 10-15), rs11625699 (14q13.1, Pcombined = 4.80 × 10-20), rs3784616 (15q21.1, Pcombined = 2.34 × 10-25), and rs16980322 (19q13.32, Pcombined = 2.75 × 10-21). Additionally, APOE rs405509 (Pcombined = 9.53 × 10-28), PVRL2 rs4803766 (Pcombined = 1.91 × 10-18), and PVRL2 rs387976 (Pcombined = 9.90 × 10-11) were associated with AD. These seven variants explained 15.87% of the overall variance in disease risk. For the eight previously reported SNPs selected for detection in the replication stage, only rs2070045 of SORL1 showed significant associations. Multifactor regression analysis using imputed data in APOE region found previously reported AD-associated SNPs in Caucasians remained significant in Chinese. The present GWAS identified four novel susceptibility variants for AD. The genes located near the four novel variants are functionally related to neurogenesis, suggesting neurogenesis in AD pathogenesis. This study also suggests genetic heterogeneity of AD susceptibility in Chinese and Caucasian populations. Regional association plots. Association results are shown for the analyzed SNPs with recombination rates in the four loci associated with genome-wide significance at 5q31.3 (a), 14q13.1 (b), 15q21.1 (c) and 19q13.32 (d-e). Purple diamonds represent the most significantly associated SNP in the combined analysis. The quantile-quantile (Q-Q) plot of the association results from the discovery stage analysis (993 AD cases and 6,451 controls). Displayed are observed versus expected -log10 P values for all variants. The yellow line indicates the expected distribution of - log10 P values under the null hypothesis. The plot in purple is for SNPs excluding previously reported SNPs with P > 10-12 (λGC = 1.038).

Polygenic risk score analysis identifies deleterious protein-coding variants in novel immune pathway genes ATP8B4, FCGR1A, and LILRB1 that associate with Alzheimer's disease.

FOUR NOVEL SUSCEPTIBILITY VARIANTS IDENTIFIED IN CHINESE ARE ASSOCIATED WITH SPORADIC ALZHEIMER’S DISEASE

Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease

Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease

A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression

Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease

Analysis of 470,000 exome-sequenced UK Biobank participants identifies genes containing rare variants which confer dementia risk

Association of CR1, CLU and PICALM with Alzheimer's Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals.

Associations of Alzheimer’s Disease Risk Variants with Gene Expression, Amyloidosis, Tauopathy, and Neurodegeneration

Network-based Analysis on Genetic Variants Reveals the Immunological Mechanism Underlying Alzheimer's Disease.

Identifying Genes Associated with Alzheimer's Disease Using Gene-Based Polygenic Risk Score

Targeted sequencing on neurodegenerative genes identified novel causal and risk variants of familial Alzheimer's disease

Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.

Association of Rare Variants in Neurodegenerative Genes with Familial Alzheimer's Disease.

Genetic Studies of Alzheimer's Disease Risk Implicate Clearance of Lipid Rich Debris in Myeloid Cells

Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis

Variants Near X‐Chromosome Genes NLGN4X and PTCHD1 Are Significantly Associated with Alzheimer’s Disease Risk

Genetic and multi-omic risk assessment of Alzheimer's disease implicates core associated biological domains

Deep Post-Gwas Analysis Identifies Potential Risk Genes and Risk Variants for Alzheimer’s Disease, Providing New Insights into Its Disease Mechanisms

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals